1. OP0154 Integrated Safety Analysis of Tofacitinib in RA Clinical Trials with A Cumulative Exposure of 12, 664 Patient-Years. (10th June 2014) Authors: Cohen, S.; Tanaka, Y.; Mariette, X.; Curtis, J.; Kwok, K.; Lee, E.; Nash, P.; Winthrop, K.; Charles-Schoeman, C.; Thirunavukkarasu, K.; Anisfeld, A.; Wang, L.; Riese, R.; Wollenhaupt, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0346 Risk Characterisation Methodology Enabling Safety Comparisons Between Tofacitinib and Tumour Necrosis Factor Inhibitors. (9th June 2015) Authors: Curtis, J.R.; Klareskog, L.; Zhang, R.; Krishnaswami, S.; Anisfeld, A.; Chen, Y.; Geier, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0179 Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-label, Long-term Extension up to 6 Years. (9th June 2015) Authors: Wollenhaupt, J.; Silverfield, J.; Lee, E.B.; Wood, S.P.; Terry, K.K.; Nakamura, H.; Kwok, K.; Anisfeld, A.; Nduaka, C.; Wang, L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0199 Tofacitinib, An Oral Janus Kinase Inhibitor, in The Treatment of Rheumatoid Arthritis: Changes in Lymphocytes and Lymphocyte Subset Counts and Reversibility after Up To 8 Years of Tofacitinib Treatment. (15th July 2016) Authors: van Vollenhoven, R.; Choy, E.; Lee, E.B.; Hazra, A.; Anisfeld, A.; Lazariciu, I.; Biswas, P.; Lamba, M.; Menon, S.; Hodge, J.; Clark, J.D.; Wang, L.; Krishnaswami, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗